EMA sticks to the recommendation of Astrazeneca's covid-vaccine

The EMA has announced that it sees a possible connection between Astrazeneca's Covid-19 vaccine and some highly rare cases of blood clots following vaccinations, but it maintains its recommendations to keep using the vaccine.
Photo: STAFF/REUTERS / X01095
Photo: STAFF/REUTERS / X01095
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN

The European Medicines Agency thinks that the advantages of the Astrazeneca vaccine against Covid-19 outweigh the disadvantages by far, states the agency at a press conference Wednesday afternoon.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading